Clinical Trial: A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)

U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07121959) titled 'A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)' on Aug. 12.

Brief Summary: The goal of this study is to learn how belzutifan (MK-6482) affects the levels of metformin in a healthy person's body over time. Researchers will study levels of metformin in the blood and urine in healthy volunteers after taking metformin alone (Period 1) and metformin with belzutifan (Period 2).

Study Start Date: Aug. 18

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Metformin

Oral Tablet

DRUG: Belzutifan

Oral Tablet

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme ...